Office of Infectious Disease Services

Reporting By Health Care Providers, Health Care Institutions, and Correctional Facilities

When should I report?

Most disease reports should be submitted within five (5) working days of diagnosis, treatment, or detection.  However, some conditions must be reported within 24 hours or only during outbreaks. 

Please see the Reportable Disease ListPDF for complete reporting specifications and timelines.

Who should receive the report?

Reports should be sent to the local health agency (county or tribal health department or Indian Health Service Unit) by mail, telephone, or fax.

Providers may also report cases of communicable disease through web entry using Arizona's Medical Electronic Disease Surveillance Intelligence System (MEDSIS). For more information, please visit the MEDSIS page.

What information is required?

Reports should include the patient's name, telephone number, complete street address, date of birth, race, sex, ethnicity, date of onset, diagnosis, date of diagnosis, laboratory results and date, name of reporter, and the reporter's telephone number and complete address.  Submit mailed or faxed reports on the Communicable Disease Reporting formPDF.

Which communicable diseases are reportable?

See the Reportable Disease ListPDF for complete specifications and timelines.

  • Amebiasis
  • Anthrax
  • Aseptic meningitis: viral
  • Basidiobolomycosis
  • Botulism
  • Brucellosis
  • Campylobacteriosis
  • Chagas disease (American trypanosomiasis)
  • Chancroid (Haemophilus ducreyi)
  • Chlamydia infection, sexually transmitted
  • Cholera
  • Coccidioidomycosis (Valley Fever)
  • Colorado tick fever
  • Conjunctivitis: acute (outbreaks only)
  • Creutzfeldt-Jakob disease
  • Cryptosporidiosis
  • Cyclospora infection
  • Cysticercosis
  • Dengue
  • Diarrhea, nausea, or vomiting (outbreaks only)
  • Diphtheria
  • Ehrlichiosis and Anaplasmosis
  • Emerging or exotic disease
  • Encephalitis: Viral or parasitic
  • Enterohemorrhagic Escherichia coli
  • Enterotoxigenic Escherichia coli
  • Giardiasis
  • Gonorrhea
  • Haemophilus influenzae : invasive disease
  • Hansen's disease (Leprosy)
  • Hantavirus infection
  • Hemolytic uremic syndrome
  • Hepatitis A
  • Hepatitis B
  • Hepatitis C
  • Hepatitis D & E
  • Herpes genitalis
  • Human Immunodeficiency Virus (HIV) infection and related disease
  • Influenza-associated mortality in a child
  • Kawasaki syndrome
  • Legionellosis (Legionnaires' Disease)
  • Leptospirosis
  • Listeriosis
  • Lyme disease
  • Lymphocytic choriomeningitis
  • Malaria
  • Measles (rubeola)
  • Meningococcal Invasive Disease
  • Mumps
  • Pertussis (whooping cough)
  • Plague
  • Poliomyelitis
  • Psittacosis (ornithosis)
  • Q Fever
  • Rabies in a human
  • Relapsing Fever (borreliosis)
  • Reye Syndrome
  • Rocky Mountain Spotted Fever
  • Rubella (German measles)
  • Rubella syndrome, congenital
  • Salmonellosis
  • Scabies (outbreaks only)
  • Severe acute respiratory syndrome (SARS)
  • Shigellosis
  • Smallpox
  • Streptococcal Group A: invasive disease
  • Streptococcal Group B: invasive disease in infants less than 90 days of age
  • Streptococcus pneumoniae (pneumococcal invasive disease)
  • Syphilis
  • Taeniasis
  • Tetanus
  • Toxic Shock Syndrome
  • Trichinosis
  • Tuberculosis, active disease
  • Tuberculosis latent infection in a child 5 years of age or younger (positive test result)
  • Tularemia
  • Typhoid fever
  • Typhus fever
  • Unexplained death with history of fever
  • Vaccinia-related adverse event
  • Vancomycin-resistant or Vancomycin-intermediately susceptible Staphylococcus aureus
  • Vancomycin-resistant Staphylococcus epidermidis
  • Varicella (chickenpox)
  • Vibrio infection
  • Viral hemorrhagic fever
  • West Nile virus infection
  • Yellow fever
  • Yersiniosis